Verrica Pharmaceuticals Inc (NASDAQ:VRCA)

3.40
Delayed Data
As of Aug 05
 +0.23 / +7.26%
Today’s Change
1.77
Today|||52-Week Range
14.79
-62.88%
Year-to-Date

Stock Price Forecast

The 4 analysts offering 12-month price forecasts for Verrica Pharmaceuticals Inc have a median target of 11.00, with a high estimate of 15.00 and a low estimate of 4.00. The median estimate represents a +223.53% increase from the last price of 3.40.

Analyst Recommendations

The current consensus among 5 polled investment analysts is to Buy stock in Verrica Pharmaceuticals Inc. This rating has held steady since June, when it was unchanged from a Buy rating.Move your mouse over past
months for detail

 
 
 
 
 
 
 
 

Earnings and Sales Forecasts

Current Quarter

Earnings per Share
-$0.32
Sales
$312.5K
Reporting Date
Aug 10

Earnings per Share

Move your mouse over a quarter or year to see how estimates have changed over time.

Growthquarterly -3.23%
 
 
 
 
 
 
Growthannually 13.69%
 
 
 
 
 
 

Sales

Growthquarterly -27.49%
 
 
 
 
 
 
Growthannually -90.98%
 
 
 
 
 
 
Key to the earnings and sales forecast charts.